Skip to main content
Tech.euFundingExplorerBeta

AM-Pharma

AM-Pharma develops ilofotase alfa as a potential enzyme replacement therapy for adult hypophosphatasia (HPP) patients.

Utrecht, Netherlandsam-pharma.com ↗
Healthtech
← All companies
Total raised
€12M
€12,200,000
Funding rounds
1
Investors
4
distinct backers
Active since
2014-08
latest 2014-08

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood19
base rate 53% for Series D+
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2014-09-01Series D+€12MAbbvie Biotech Ventures,Gilde Healthcare,Inventages Venture Capital,Ysios CapitalView deal →

Investors

4
Abbvie Biotech VenturesGilde HealthcareInventages Venture CapitalYsios Capital

Similar companies

same sector or country